Lenvatinib mesylate
Lenvatinib mesylate (E7080 mesylate), an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, shows potent antitumor activities.
Product Specifications
CAS Number
857890-39-2
Product Name Alternative
E7080 mesylate
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
DMSO : 7.35 mg/mL (14.05 mM; Need ultrasonic)
Smiles
O=C (C1=C (OC) C=C2N=CC=C (OC3=CC=C (NC (NC4CC4) =O) C (Cl) =C3) C2=C1) N.OS (=O) (C) =O
Molecular Formula
C??H??ClN?O?S
Molecular Weight
522.96
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-61619R-RBITC-01 20 µL
CCR8 Recombinant Antibody, RBITC Conjugated
Sign In for Pricing
View Details bsm-61619R-RBITC-02 100 µL
CCR8 Recombinant Antibody, RBITC Conjugated
Sign In for Pricing
View Details 